An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination

被引:5
|
作者
Yoshimura, Yukihiro [1 ]
Sasaki, Hiroaki [1 ]
Miyata, Nobuyuki [1 ]
Miyazaki, Kazuhito [2 ]
Okudela, Koji [3 ]
Tateishi, Yoko [4 ]
Hayashi, Hiroyuki [4 ]
Kawana-Tachikawa, Ai [5 ]
Iwashita, Hiromichi [3 ]
Maeda, Kazuho [6 ]
Ihama, Yoko [6 ]
Hatayama, Yasuyoshi [7 ]
Ryo, Akihide [7 ]
Tachikawa, Natsuo [1 ]
机构
[1] Yokohama Municipal Citizens Hosp, Dept Infect Dis, Yokohama, Kanagawa, Japan
[2] Yokohama Municipal Citizens Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan
[3] Yokohama City Univ, Dept Pathol, Grad Sch Med, Yokohama, Kanagawa, Japan
[4] Yokohama Municipal Citizens Hosp, Dept Pathol, Yokohama, Kanagawa, Japan
[5] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan
[6] Yokohama City Univ, Dept Legal Med, Grad Sch Med, Yokohama, Kanagawa, Japan
[7] Yokohama City Univ, Dept Microbiol, Sch Med, Yokohama, Kanagawa, Japan
关键词
COVID-19; vaccine; acute respiratory distress syndrome; autopsy;
D O I
10.1016/j.ijid.2022.04.057
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We report the first case with COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination. An 88-year-old woman developed dyspnea several hours after vaccination with the second dose of mRNA-1273. She was hospitalized on day nine due to worsening dyspnea. Chest computed tomography showed bilateral ground-glass opacities and consolidations, mainly in the peripheral lung areas. Repeat polymerase chain reaction tests for SARS-CoV-2 were negative, although the serum level of antibodies against spike protein was extremely elevated. Her condition did not improve with high-dose corticosteroids and high-flow nasal cannula oxygen therapy; she died on day 18. Autopsy findings revealed very early-phase diffuse alveolar damage in the whole lung without other lung diseases. The clinical and pathological findings suggested vaccine-induced acute respiratory distress syndrome. Serological and pathological tests might be useful to differentiate the disease from COVID-19. (C) 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:98 / 101
页数:4
相关论文
共 50 条
  • [41] SARS-CoV-2 causes COVID-19-like disease in cynomolgus macaques
    Alexandra Le Bras
    Lab Animal, 2020, 49 : 174 - 174
  • [42] Development of pemphigus vulgaris after the second dose of the mRNA-1273 SARS-Cov-2 vaccine
    Koutlas, Ioannis G.
    Camara, Renee
    Argyris, Prokopios P.
    Davis, Mark Denis P.
    Miller, Daniel D.
    ORAL DISEASES, 2022, 28 : 2612 - 2613
  • [43] Bell's Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine
    Iftikhar, Haris
    Noor, Syeda Mishkaat U.
    Masood, Maarij
    Bashir, Khalid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [44] Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
    Anderson, E. J.
    Rouphael, N. G.
    Widge, A. T.
    Jackson, L. A.
    Roberts, P. C.
    Makhene, M.
    Chappell, J. D.
    Denison, M. R.
    Stevens, L. J.
    Pruijssers, A. J.
    McDermott, A. B.
    Flach, B.
    Lin, B. C.
    Doria-Rose, N. A.
    O'Dell, S.
    Schmidt, S. D.
    Corbett, K. S.
    Swanson, P. A., II
    Padilla, M.
    Neuzil, K. M.
    Bennett, H.
    Leav, B.
    Makowski, M.
    Albert, J.
    Cross, K.
    Edara, V. V.
    Floyd, K.
    Suthar, M. S.
    Martinez, D. R.
    Baric, R.
    Buchanan, W.
    Luke, C. J.
    Phadke, V. K.
    Rostad, C. A.
    Ledgerwood, J. E.
    Graham, B. S.
    Beigel, J. H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (25): : 2427 - 2438
  • [45] SARS-CoV-2 causes COVID-19-like disease in cynomolgus macaques
    Le Bras, Alexandra
    LAB ANIMAL, 2020, 49 (06) : 174 - 174
  • [46] Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
    El Sahly, H. M.
    Baden, L. R.
    Essink, B.
    Doblecki-Lewis, S.
    Martin, J. M.
    Anderson, E. J.
    Campbell, T. B.
    Clark, J.
    Jackson, L. A.
    Fichtenbaum, C. J.
    Zervos, M.
    Rankin, B.
    Eder, F.
    Feldman, G.
    Kennelly, C.
    Han-Conrad, L.
    Levin, M.
    Neuzil, K. M.
    Corey, L.
    Gilbert, P.
    Janes, H.
    Follmann, D.
    Marovich, M.
    Polakowski, L.
    Mascola, J. R.
    Ledgerwood, J. E.
    Graham, B. S.
    August, A.
    Clouting, H.
    Deng, W.
    Han, S.
    Leav, B.
    Manzo, D.
    Pajon, R.
    Schodel, F.
    Tomassini, J. E.
    Zhou, H.
    Miller, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (19): : 1774 - 1785
  • [47] Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine
    de Assis, Felipe Lopes
    Hoehn, Kenneth B.
    Zhang, Xiaozhen
    Kardava, Lela
    Smith, Connor D.
    El Merhebi, Omar
    Buckner, Clarisa M.
    Trihemasava, Krittin
    Wang, Wei
    Seamon, Catherine A.
    Chen, Vicky
    Schaughency, Paul
    Cheung, Foo
    Martins, Andrew J.
    Chiang, Chi-, I
    Li, Yuxing
    Tsang, John S.
    Chun, Tae-Wook
    Kleinstein, Steven H.
    Moir, Susan
    CELL REPORTS, 2023, 42 (07):
  • [48] Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
    Evan J Anderson
    四川生理科学杂志, 2020, 42 (04) : 468 - 468
  • [49] Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants
    Choi, Angela
    Koch, Matthew
    Wu, Kai
    Dixon, Groves
    Oestreicher, Judy
    Legault, Holly
    Stewart-Jones, Guillaume B. E.
    Colpitts, Tonya
    Pajon, Rolando
    Bennett, Hamilton
    Carfi, Andrea
    Edwards, Darin K.
    JOURNAL OF VIROLOGY, 2021, 95 (23)
  • [50] Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination
    Shin, Sun Hye
    Hong, Jun Ki
    Hong, Soon Auck
    Li, Kapsok
    Yoo, Kwang Ho
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 114 : 88 - 89